Melatonin restores endothelium-dependent relaxation in aortic rings of pancreatectomized rats

Journal of Pineal Research

Volumn 39, Issue 4, 2005, Pages 386-391

  Reyes Toso, Carlos F ^a   Linares, Laura M ^a   Ricci, Conrado R ^a   Obaya Naredo, Daniel ^a   Pinto, Jorge E ^a   Rodríguez, Ricardo R ^a   Cardinali, Daniel P ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Diabetes; Endothelium; Melatonin; Nitric oxide; Pancreatectomy; Vascular reactivity

Indexed keywords

ACETYLCHOLINE; MELATONIN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE INHIBITOR; NITROPRUSSIDE SODIUM; GLUCOSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DOSE RESPONSE; GLUCOSE INTAKE; HORMONE ACTION; HYPERGLYCEMIA; MALE; NONHUMAN; PANCREAS RESECTION; RAT; VASCULAR RING; VASODILATATION; ANIMAL; AORTA; DRUG EFFECT; EXPERIMENTAL DIABETES MELLITUS; INSULIN DEPENDENT DIABETES MELLITUS; MUSCLE RELAXATION; PATHOPHYSIOLOGY; PHYSIOLOGY; VASCULAR ENDOTHELIUM; WISTAR RAT;

ACETYLCHOLINE; ANIMALS; AORTA; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; ENDOTHELIUM, VASCULAR; GLUCOSE; MALE; MELATONIN; MUSCLE RELAXATION; NG-NITROARGININE METHYL ESTER; NITROPRUSSIDE; PANCREATECTOMY; RATS; RATS, WISTAR;

EID: 27744459508     PISSN: 07423098     EISSN: 1600079X     Source Type: Journal    
DOI: 10.1111/j.1600-079X.2005.00262.x     Document Type: Article

References (44)

1. Pieper GM. Review of alterations in endothelial nitric oxide production in diabetes: protective role of arginine on endothelial dysfunction. Hypertension 1998 31 : 1047 1060.
2. Sowers JR Epstein M. Diabetes mellitus and associated hypertension, vascular disease, and nephropathy. An update. Hypertension 1995 26 : 869 879.
3. Komori K Vanhoutte PM. Endothelium-derived hyperpolarizing factor. Blood Vessels 1990 27 : 238 245.
4. Moncada S Palmer RMJ Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991 43 : 109 142.
5. Calles-Escandon J Cipolla M. Diabetes and endothelial dysfunction: a clinical perspective. Endocr Rev 2001 22 : 36 52.
6. Tesfamariam B Cohen RA. Free radicals mediate endothelial cell dysfunction caused by elevated glucose. Am J Physiol Heart Circ Physiol 1992 263 : H321 H326.
7. Rodriguez-Manas L Angulo J Peiro C et al. Endothelial dysfunction and metabolic control in streptozotocin-induced diabetic rats. Br J Pharmacol 1998 123 : 1495 1502.
8. Chan NN Vallance P Colhoun HM. Nitric oxide and vascular responses in type I diabetes. Diabetologia 2000 43 : 137 147.
9. Brodsky SV Morrishow AM Dharia N et al. Glucose scavenging of nitric oxide. Am J Physiol Renal Physiol 2001 280 : F480 F486.
10. Reyes-Toso CF Roson MI Albornoz LE et al. Vascular reactivity in diabetic rats: effect of melatonin. J Pineal Res 2002 33 : 81 86.
11. Reyes-Toso CF Linares LM Ricci CR et al. Effect of melatonin on vascular reactivity in pancreatectomized rats. Life Sci 2004 74 : 3085 3092.
12. Bohlen HG Lash JM. Topical hyperglycemia rapidly suppresses EDRF-mediated vasodilation of normal rat arterioles. Am J Physiol 1993 265 : H219 H225.
13. 2+ oscillation in cultured endothelial cells from bovine aorta: a possible role of superoxide anion. Circ Res 1998 82 : 677 685.
14. Cohen RA Vanhoutte PM. Endothelium-dependent hyperpolarization: beyond nitric oxide and cyclic GMP. Circulation 1995 92 : 3337 3349.
15. Foglia V. Características de la diabetes en la rata. Rev Soc Arg Biol 1944 20 : 21 37.
16. Gryglewski RJ Palmer RM Moncada S. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature 1986 320 : 454 456.
17. Koya D King GL. Protein kinase C activation and the development of diabetic complications. Diabetes 1998 47 : 859 866.
18. Beckman JA Goldfine AB Gordon MB et al. Inhibition of protein kinase C prevents impaired endothelium-dependent vasodilation caused by hyperglycemia in humans. Circ Res 2002 90 : 107 111.
19. Gutterman DD. Vascular dysfunction in hyperglycemia: is protein kinase C the culprit Circ Res 2002 90 : 5 7.
20. Tan DX Chen B Poeggeler B et al. Melatonin: a potent, endogenous hydroxyl radical scavenger. Endocr J 1993 1 : 57 60.
21. Allegra M Reiter RJ Tan DX et al. The chemistry of melatonin's interaction with reactive species. J Pineal Res 2003 34 : 1 10.
22. Giugliano D Ceriello A Paolisso G. Oxidative stress and diabetic vascular complications. Diabetes Care 1996 19 : 257 267.
23. Montilla PL Vargas JF Tunez IF et al. Oxidative stress in diabetic rats induced by streptozotocin: protective effects of melatonin. J Pineal Res 1998 25 : 94 100.
24. Pieper GM Gross GJ. Oxygen free radicals abolish endothelium-dependent relaxation in diabetic rat aorta. Am J Physiol 1988 255 : H825 H833.
25. Baydas G Canatan H Turkoglu A. Comparative analysis of the protective effects of melatonin and vitamin E on streptozocin-induced diabetes mellitus. J Pineal Res 2002 32 : 225 230.
26. Tan DX Manchester LC Hardeland R et al. Melatonin: a hormone, a tissue factor, an autocoid, a paracoid, and an antioxidant vitamin. J Pineal Res 2003 34 : 75 78.
27. Marshall KA Reiter RJ Poeggeler B et al. Evaluation of the antioxidant activity of melatonin in vitro. Free Radic Biol Med 1996 21 : 307 315.
28. Pieri C Moroni F Marra M et al. Melatonin is an efficient antioxidant. Arch Gerontol Geriatr 1995 20 : 159 165.
29. Gilad E Cuzzocrea S Zingarelli B et al. Melatonin is a scavenger of peroxynitrite. Life Sci 1997 60 : L169 L174.
30. Reiter RJ. Functional pleiotropy of the neurohormone melatonin: antioxidant protection and neuroendocrine regulation. Front Neuroendocrinol 1995 16 : 383 415.
31. Rodriguez C Mayo JC Sainz RM et al. Regulation of antioxidant enzymes: a significant role for melatonin. J Pineal Res 2004 36 : 1 9.
32. Tan DX Reiter RJ Manchester LC et al. Chemical and physical properties and potential mechanisms: melatonin as a broad spectrum antioxidant and free radical scavenger. Curr Top Med Chem 2002 2 : 181 197.
33. Tan DX Hardeland R Manchester LC et al. Mechanistic and comparative studies of melatonin and classic antioxidants in terms of their interactions with the ABTS cation radical. J Pineal Res 2003 34 : 249 259.
34. 2-formyl-5-methoxykynuramine and 6-methoxymelatonin reduce oxidative DNA damage induced by Fenton reagents. J Pineal Res 2003 34 : 178 184.
35. 1-acetyl-5-methoxykynuramine (AMK): scavenging of free radicals and prevention of protein destruction. Redox Rep 2003 8 : 205 213.
36. 2-formyl-5-methoxykynuramine is a product of melatonin oxidation in rats. J Pineal Res 2003 35 : 245 250.
37. Silva SO Rodrigues MR Carvalho SR et al. Oxidation of melatonin and its catabolites, N-acetyl-N-formyl-5-methoxykynuramine and N-acetyl-5- methoxykynuramine, by activated leukocytes. J Pineal Res 2004 37 : 171 175.
38. 2-formyl- 5-methoxykynuramine, quercetin or resveratrol. J Pineal Res 2005 38 : 107 115.
39. Cam M Yavuz O Guven A et al. Protective effects of chronic melatonin treatment against renal injury in streptozotocin-induced diabetic rats. J Pineal Res 2003 35 : 212 220.
40. Paskaloglu K Sener G Ayangolu-Dulger G. Melatonin treatment protects against diabetes-induced functional and biochemical changes in rat aorta and corpus cavernosum. Eur J Pharmacol 2004 499 : 345 354.
41. Haffner SM Lehto S Ronnemaa T et al. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998 339 : 229 234.
42. Cavallo A Daniels SR Dolan LM et al. Blood pressure response to melatonin in type 1 diabetes. Pediatr Diabetes 2004 5 : 26 31.
43. Cavallo A Daniels SR Dolan LM et al. Blood pressure-lowering effect of melatonin in type 1 diabetes. J Pineal Res 2004 36 : 262 266.
44. Scheer FA Van Montfrans GA Van Someren EJ et al. Daily nighttime melatonin reduces blood pressure in male patients with essential hypertension. Hypertension 2004 43 : 192 197.